GlassScriptPhysician profile
Jonathan T Eaton
NPI 1093270548
$1,979.39
in general payments reported to CMS, 2019-2025
10 companies · $1,769 in 2025
The $1,769 reported for 2025 was more than what 95% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $133 · 2023: $53.99 · 2024: $23.05 · 2025: $1,769.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,138 · Food and Beverage: $708.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,137.83 |
| Food and Beverage | $708.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $1,365.52 | 2025 | Stratafix |
| Ethicon US, LLC | $156.07 | 2025 | Vistaseal, Stratafix |
| Davol INC. | $133.48 | 2022 | |
| Amgen INC. | $129.42 | 2025 | Evenity |
| Providence Medical Technology, INC. | $57.17 | 2025 | |
| Depuy Synthes Sales INC. | $53.99 | 2023 | Matrixrib, Matrixneuro, Synthecel |
| Convatec INC. | $23.05 | 2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $22.94 | 2025 | Relistor |
| Boston Scientific Corporation | $19.73 | 2025 | Intracept |
| Vertex Pharmaceuticals Incorporated | $18.02 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Eaton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.